Research Article
Novel Microdilution Method to Assess Double and Triple Antibiotic Combination Therapy In Vitro
Table 2
Susceptibility of Pseudomonas aeruginosa clinical isolates to the antibiotics.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(i) The MIC is the minimum inhibitory concentration; MBC is defined as the concentration required to kill 99.9% of the bacteria. (ii) The MICs of the tested antibiotics were determined by broth microdilution method. (iii) The R letter denotes resistance of the isolate to the antibiotic based on the EUCAST MIC breakpoint guideline [21]. (iv) CIP, ciprofloxacin; AMK, amikacin; CAZ, ceftazidime; PIP, piperacillin; IMP, imipenem. |